Xeris Pharmaceuticals Inc reported $-18916000 in Operating Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Acelrx Pharmaceuticals ACRX:US $ -13573000 4.58M
Eli Lilly And LLY:US $ 1210.1M 1194.2M
Horizon Pharma HZNP:US $ 88.56M 105.76M
JAZZ PHA JAZZ:US $ 85.55M 2M
Nektar Therapeutics NKTR:US $ -152.84M 36.28M
Pacira Pharmaceuticals PCRX:US $ 31.24M 13.84M
Perrigo Ordinary Shares PRGO:US $ -16.2M 37.9M
Supernus Pharmaceuticals SUPN:US $ 11.35M 9.38M
Teva Pharmaceutical Industries TEVA:US $ -949M 236M